Issue 86, 2022

Mannobioside biomimetics that trigger DC-SIGN binding selectivity

Abstract

Selective DC-SIGN targeting vs. langerin might lead to anti-infective agents, given their counteracting effects upon infection by some pathogens. Here we show that multivalent sp2-iminosugar-containing mannobioside analogs can achieve total DC-SIGN selectivity by levering the canonic binding mode towards high-mannose oligosaccharide ligands, behaving as factual biomimics.

Graphical abstract: Mannobioside biomimetics that trigger DC-SIGN binding selectivity

Supplementary files

Article information

Article type
Communication
Submitted
12 Aug 2022
Accepted
05 Oct 2022
First published
06 Oct 2022

Chem. Commun., 2022,58, 12086-12089

Mannobioside biomimetics that trigger DC-SIGN binding selectivity

I. Herrera-González, M. Thépaut, E. M. Sánchez-Fernández, A. di Maio, C. Vivès, J. Rojo, J. M. García Fernández, F. Fieschi, P. M. Nieto and C. Ortiz Mellet, Chem. Commun., 2022, 58, 12086 DOI: 10.1039/D2CC04478A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements